Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Trey Thoelcke | Nov 5, 2012 at 8:08 AM EST

Humana Lifts EPS Outlook, Announces Acquisition

ThinkstockHumana Inc. (NYSE: HUM) said this morning that its third-quarter net income fell 4.3% but it lifted its earnings outlook…

Jon C. Ogg | Nov 1, 2012 at 7:37 AM EDT

Pfizer Earnings Dragged by Lipitor and Nexium

Wikimedia CommonsPfizer Inc. (NYSE: PFE) is out with its earnings report for the third quarter, and the drug giant reported…

Jon C. Ogg | Oct 30, 2012 at 3:26 PM EDT

DaVita Offers Full 2013 Earnings Outlook Including HCP Acquisition

DaVita Inc. (NYSE: DVA) has been running very well and it was no mystery as to why Warren Buffett’s new…

Jon C. Ogg | Oct 29, 2012 at 11:58 AM EDT

FDA Gives Nod to Onyx and Bayer for Stivarga in Gastrointestinal Tumors

via Wikimedia CommonsThere is some potentially very good news for those with gastrointestinal stromal tumors. The FDA has granted a…

Trey Thoelcke | Oct 26, 2012 at 7:32 AM EDT

Merck’s Q3 Revenues Dinged by Patent Expiry

Merck & Co. (NYSE: MRK) this morning reported better-than-expected third-quarter earnings, but the loss of market exclusivity for its Singulair…

Trey Thoelcke | Oct 25, 2012 at 7:41 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Trey Thoelcke | Oct 24, 2012 at 7:39 AM EDT

Generics Take a Bite of Eli Lilly Q3 Results

Eli Lilly (NYSE: LLY) this morning reported disappointing third-quarter results as generic drugs took a toll on its sales. The…

Jon C. Ogg | Oct 23, 2012 at 10:29 AM EDT

Success in Rectal Cancer, Success for BSD Medical

BSD Medical Corp. (NASDAQ: BSDM) is seeing its shares surge on positive news about tumors in rectal cancer. The company…

Trey Thoelcke | Oct 22, 2012 at 8:59 AM EDT

Pfizer to Buy NextWave Pharmaceuticals

Pfizer Inc. (NYSE: PFE) said today that it will acquire privately held NextWave Pharmaceuticals. NextWave is a specialty pharmaceutical company…

Trey Thoelcke | Oct 19, 2012 at 10:05 AM EDT

WebMD Extends Poison Pill for Two More Years

WebMD Health Corp. (NASDAQ: WBMD) said that on Thursday its board of directors has signed off an amendment to its…

Mike Sauter | Oct 19, 2012 at 6:46 AM EDT

States with the Fewest (and Most) Doctors

The U.S. is currently facing a severe shortage of doctors. The Association of American Medical Colleges predicts that by 2020,…

Douglas A. McIntyre | Oct 19, 2012 at 6:27 AM EDT

The Unsolved Uninsured Problem

The new and remarkably large health care law, based on the vision of President Obama, will phase in quickly over the…

Paul Ausick | Oct 17, 2012 at 11:56 AM EDT

Centene Puts Kentucky in Rear-view Mirror (CNC, WCG, CVH)

Medicaid insurance provider Centene Corp. (NYSE: CNC) today announced that it is exercising its contractual right to discontinue offering its…

Trey Thoelcke | Oct 17, 2012 at 9:02 AM EDT

Abbott Labs Q3 Profit Surges, but Revenues Slip

Abbott Laboratories (NYSE: ABT) said that third-quarter earnings surged, despite a slip in revenue, due to a double-digit decline in…

Jon C. Ogg | Oct 16, 2012 at 3:59 PM EDT

Options Evaluation After FDA Panel Backing For NPS Pharma

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) may not yet have formal approval for its short bowel syndrome drug called Gattex, but…

1 … 311 312 313 314 315 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Humana Lifts EPS Outlook, Announces Acquisition

Pfizer Earnings Dragged by Lipitor and Nexium

DaVita Offers Full 2013 Earnings Outlook Including HCP Acquisition

FDA Gives Nod to Onyx and Bayer for Stivarga in Gastrointestinal Tumors

Merck’s Q3 Revenues Dinged by Patent Expiry

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Generics Take a Bite of Eli Lilly Q3 Results

Success in Rectal Cancer, Success for BSD Medical

Pfizer to Buy NextWave Pharmaceuticals

WebMD Extends Poison Pill for Two More Years

States with the Fewest (and Most) Doctors

The Unsolved Uninsured Problem

Centene Puts Kentucky in Rear-view Mirror (CNC, WCG, CVH)

Abbott Labs Q3 Profit Surges, but Revenues Slip

Options Evaluation After FDA Panel Backing For NPS Pharma

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

Humana Lifts EPS Outlook, Announces Acquisition

Pfizer Earnings Dragged by Lipitor and Nexium

DaVita Offers Full 2013 Earnings Outlook Including HCP Acquisition

FDA Gives Nod to Onyx and Bayer for Stivarga in Gastrointestinal Tumors

Merck’s Q3 Revenues Dinged by Patent Expiry

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Generics Take a Bite of Eli Lilly Q3 Results

Success in Rectal Cancer, Success for BSD Medical

Pfizer to Buy NextWave Pharmaceuticals

WebMD Extends Poison Pill for Two More Years

States with the Fewest (and Most) Doctors

The Unsolved Uninsured Problem

Centene Puts Kentucky in Rear-view Mirror (CNC, WCG, CVH)

Abbott Labs Q3 Profit Surges, but Revenues Slip

Options Evaluation After FDA Panel Backing For NPS Pharma

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation